Complaints Filed August 2014

Date Filed: 8/11/2014
Case Number:
Plaintiff(s): Pfizer Inc.; Wyeth LLC; Wyeth Pharmaceuticals Inc.; PF Prism C.V.
Defendant(s): IntelliPharmaceutics International Inc.; IntelliPharmaceutics Corporation; IntelliPharmaceutics Ltd.
Patent Number(s): 6,673,838 (“Succinate salt of O-desmethyl-venlafaxine”); 8,269,040 (“Derivatives of venlafaxine and methods of preparing and using the same”)
Accused Products:
O-desmethylvenlafaxine succinate extended release tablets in 50 and 100 mg dosage strengths (generic versions of Pristiq®)
Complaint (PDF)

Date Filed: 8/15/2014
Case Number: 1:14-cv-06572-UA
Plaintiff(s): Edwin Lyda
Defendant(s): CBS Corporation; CBS Interactive, Inc.
Patent Number(s): 7,434,243 (“Response apparatus method and system”); 7,730,506 (“Method and apparatus for response system”)
Accused Products: Use of texting via cell phones in the Big Brother television series
Complaint (PDF)

Date Filed: 8/18/2014
Case Number: 1:14-cv-06586-JPO
Plaintiff(s): Smart Destinations, Inc.
Defendant(s): Travel Fun Card LLC; iVenture Fun Card Asia Ltd.
Patent Number(s): 7,765,128 (“Programmable ticketing system”); 8,346,618 (same)
Accused Products: Smart-card based attraction passes, e.g., Las Vegas Power Pass and Honolulu Power Pass
Complaint (PDF)

Date Filed: 8/27/2014
Case Number:
Plaintiff(s): Microscan Systems, Inc.
Defendant(s): Cognex Corporation
Patent Number(s): 6,352,204 (“Optical symbol scanner with low angle illumination”)
Accused Products: Cognex DataMan 8500
Complaint (PDF)

Date Filed: 8/29/2014
Case Number: 1:14-cv-07049-UA
Plaintiff(s): Hospira, Inc.
Defendant(s): Janssen Biotech, Inc.; New York University; NYU Langone Medical Center; The Kennedy Trust for Rheumatology Research
Patent Number(s): 6,284,471 (“Anti-TNFa antibodies and assays employing anti-TNFa antibodies”); 7,223,396 (“Methods of treatment of fistulas in Crohn's disease with anti-TNF antibodies”); 7,846,442 (“Methods of treating rheumatoid arthritis with an anti-TNF-alpha antibodies and methotrexate”); 8,298,537 (“Concomitant treatment of rheumatoid arthritis with anti-TNF-.alpha. antibodies and methotrexate”); 8,383,120 (same)
Accused Products: A biosimilar version of Ramicade®, containing as its active ingredient a monoclonal antibody, infliximab (product named in declaratory judgment)
Complaint (PDF)

The articles on our Website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice.